Publication | Closed Access

The water soluble ruthenium(II) organometallic compound [Ru( p -cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells

Tumor BiologyTumor InfiltrationMedicineWater Soluble RutheniumRegulatory T CellsCancer BiologyAnti-cancer AgentPharmacologyRadiation OncologyCancer ResearchDrug Discovery